Drugs · acquisition-cost intelligence
DEPO-MEDROL
methylprednisolone acetate· ingredient methylprednisoloneCorticosteroids, combinations for treatment of acne· METHYLPREDNISOLONE ACETATE 40 mg/mL; METHYLPREDNISOLONE ACETATE 80 mg/mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$5.81
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 6 weeks.
2025-05-212026-04-22
Same-ingredient options by acquisition cost
Other methylprednisolone products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| methylprednisolone | $0.12425 | −$5.68 |
| Medrol | $0.25840 | −$5.55 |
| methylprednisolone | $1.03 | −$4.78 |
| Methylprednisolone Sodium Succinate | $4.06 | −$1.75 |
| Solu-Medrol | $6.27 | +$0.46120 |
| Depo-Medrol | $10.97 | +$5.16 |
| Depo-Medrol | $11.96 | +$6.16 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.